- Associated Press - Wednesday, April 22, 2015

FRANKFURT, Germany (AP) - Breast cancer drugs such as Herceptin as well as new uses for multi-cancer drug Avastin helped Swiss pharmaceutical firm Roche grow sales by 3 percent during the first quarter.

Group sales rose 3 percent to 11.83 billion Swiss francs ($12.30 billion). Sales rose 5 percent if the sudden rise in the Swiss franc during the quarter is disregarded.

CEO Severin Schwan said Wednesday that “we started the year with strong growth and good uptake of new products.”

The company’s drugs for certain aggressive forms of breast cancer saw “very strong” growth of 23 percent as more doctors combined using Herceptin and Perjeta.

Avastin sales were up 6 percent after recent approvals for it to be used against additional forms of cancer.


Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide